Cargando…
Exploring existing drugs: proposing potential compounds in the treatment of COVID-19
The COVID-19 situation had escalated into an unprecedented global crisis in just a few weeks. On the 30(th) of January 2020, World Health Organization officially declared the COVID-19 epidemic as a public health emergency of international concern. The confirmed cases were reported to exceed 105,856,...
Autores principales: | Kabir, Eva Rahman, Mustafa, Nashrah, Nausheen, Nahid, Sharif Siam, Mohammad Kawsar, Syed, Easin Uddin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7906017/ https://www.ncbi.nlm.nih.gov/pubmed/33655082 http://dx.doi.org/10.1016/j.heliyon.2021.e06284 |
Ejemplares similares
-
An Empirical Analysis of the Perceived Challenges and Benefits of Introducing Biosimilars in Bangladesh: A Paradigm Shift
por: Kabir, Eva Rahman, et al.
Publicado: (2018) -
The Breakthrough of Biosimilars: A Twist in the Narrative of Biological Therapy
por: Kabir, Eva Rahman, et al.
Publicado: (2019) -
A computational approach to design potential siRNA molecules as a prospective tool for silencing nucleocapsid phosphoprotein and surface glycoprotein gene of SARS-CoV-2
por: Chowdhury, Umar Faruq, et al.
Publicado: (2021) -
Extracellular heat shock proteins and cancer: New perspectives
por: Albakova, Zarema, et al.
Publicado: (2020) -
Drug Repositioning: Exploring New Indications for Existing Drug-Disease Relationships
por: Kim, Hun-Sung
Publicado: (2022)